Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cannabis stocks are rising to new heights as the smoke begins to clear around the 2020 election. Shares in big weed companies soared on Thursday as investors began to price in a victory for pot-friendly presidential hopeful Joe Biden, even as five US states — including the conservative red state Mississippi — approved measures to.

Marijuana stocks surge as investors bet on a more weed-friendly US

Upwork Inc

Nio, Aurora Cannabis, Tilray and Upwork were our top stock trades for Friday. Let's take a look at the charts to see why.

4 Top Stock Trades for Friday: NIO, ACB, TLRY, UPWK

It's the impact of the U.S. elections -- but with a different twist this time.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Are Rebounding Today

Aphria

Cronos Group

Share prices of most large publicly traded marijuana stocks dropped Wednesday, in a range of a modest 0.4% for Aphria Inc.

Have You Already Missed Your Chance to Buy the Dip in Marijuana Stocks?

Cannabis legalization was on five state ballots yesterday and ran the table. All the measures passed, making cannabis legal, in some form, in five new states.

Cannabis legalization measures set to pass in 5 states

Amplify Alternative Harvest ETF

The legalization of recreational cannabis sales in four states was not enough to help boost cannabis stocks as the prospect of a Republican controlled Senate dimmed investor hopes for swift federal legalization of the drug. On Tuesday, Arizona, New Jersey, and Montana legalized the recreational sale of cannabis in state-wide ballot initiatives. South Dakota legalized the sale of both medical and recreational cannabis in its state. The successful ballot initiatives mean a full one-third of Americans now live in a state where the sale of recreational cannabis are legal.

Cannabis stocks drop as the possibility of a Republican Senate dims federal legalization hopes

Shares of cannabis company's fell in early trading Wednesday, as investor disappointment that a Democratic sweep failed to materialize offset a boost from referendum wins in a number states.

Cannabis stocks fall as a failed Democratic sweep offsets state referendum wins

GrowGeneration Corp

HEXO Corp

OrganiGram Holdings Inc.

Trulieve Cannabis Corp.

Always look at the stocks any exchange-traded fund holds.

Will Marijuana's Biggest ETF Miss the Cannabis Rebound?

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports third-quarter 2020 results.

Is a Disappointment in Store for Tilray's (TLRY) Q3 Earnings?

It was all about (potential) legalization.

Why Marijuana Stocks Like Cronos, Tilray, and HEXO Blasted Higher Today

Innovative Industrial Properties

Scotts Miracle-Gro

Find out what sent cannabis companies through the roof.

Stock Markets Bounced Monday, but These Pot Stocks Really Smoked Higher

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday, November 9, 2020 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-407-0792 from the U.S. and 201-689

Tilray to Report Third Quarter 2020 Financial Results on November 9, 2020

Altria

Constellation Brands

The U.S. election could be a bullish catalyst for marijuana stocks. However, a "blue wave" would be better for certain stocks than others.

Ranking the ‘Big 4' Canadian Marijuana Stocks From Best to Worst

Last week's Election 2020 debate was a disappointment -- for cannabis fans.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Were Down 5% (and More) on Monday

Legalizing marijuana is often cited as a way to mitigate fiscal deficits for states and countries.

Can Legal Cannabis Relieve Fiscal Deficits? These Economists Say 'Not Necessarily'

Curaleaf Holdings, Inc.

Village Farms International

Nothing is guaranteed for any of these stocks, but their potential upsides might be too big to pass up.

4 Best Cannabis Stocks Under $10

Canadians are smoking 'em if they got 'em.

Why Marijuana Stocks Canopy Growth, Tilray, and Aurora Cannabis All Rose on Wednesday

It's nothing but the volatility that's typical for Canadian pot stocks.

Why Marijuana Stocks Aurora Cannabis, Canopy Growth, and Tilray Are Giving Up Much of Monday's Gains

Within a month, marijuana could be mostly legal in 3 out of 4 U.S. states.

Why Marijuana Stocks Are Rocking Monday

Axsome Therapeutics

Madrigal Pharmaceuticals

Nikola

When it comes to extreme wealth creation, few endeavors can compare to being an owner of a small-cap stock that grows large. The post Small-Cap Stocks Have Led Every Bull Market for Decades appeared first on InvestorPlace.

Small-Cap Stocks Have Led Every Bull Market for Decades

When Will Canadian Marijuana Stocks Be Profitable?

Tilray stock is surging based on bullish sentiment for marijuana in a Biden administration. Investors need hear what is really being said.

Tilray Needs More Than Words to Become a Viable Trade

U.S.-listed shares of major cannabis producers surged on Thursday after Democratic vice president nominee Kamala Harris said marijuana would be decriminalized at a federal level in the United States under a Biden administration. During Wednesday night’s debate with Vice President Mike Pence, Harris said she and Democratic presidential nominee Joe Biden would also expunge the.

Weed stocks surge as Kamala Harris vows to decriminalize pot in debate

GW Pharmaceuticals

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Investing in marijuana is speculative, but, with these marijuana ETFs you can get in on the cannabis investing game and reduce risk. The post The 5 Best Marijuana ETFs for Conservative Portfolios appeared first on InvestorPlace.

The 5 Best Marijuana ETFs for Conservative Portfolios

Hint: The reason starts with the letter "D."

Why Marijuana Stocks Tilray, HEXO, and Cronos Group Were on Fire Thursday

News for Tilray Brands Stock (TLRY)